MBNL2
Muscleblind-like protein 2
Also known as: MBLL, MBLL39, MBNL2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5VZF2
- Gene
- MBNL2
- Ensembl
- ENSG00000139793
- Chromosome
- 13
- Canonical length
- 373 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene is a member of the muscleblind protein family which was initially described in Drosophila melanogaster. This gene encodes a C3H-type zinc finger protein that modulates alternative splicing of pre-mRNAs. Muscleblind proteins bind specifically to expanded dsCUG RNA but not to normal size CUG repeats and may thereby play a role in the pathophysiology of myotonic dystrophy. Several alternatively spliced transcript variants have been described but the full-length natures of only some have been determined. [provided by RefSeq, Mar 2012]
Canonical amino-acid sequenceUniProt
373 residues, UniProt reviewed canonical sequence.
>Q5VZF2|MBNL2
1 MALNVAPVRD TKWLTLEVCR QFQRGTCSRS DEECKFAHPP KSCQVENGRV IACFDSLKGR
61 CSRENCKYLH PPTHLKTQLE INGRNNLIQQ KTAAAMLAQQ MQFMFPGTPL HPVPTFPVGP
121 AIGTNTAISF APYLAPVTPG VGLVPTEILP TTPVIVPGSP PVTVPGSTAT QKLLRTDKLE
181 VCREFQRGNC ARGETDCRFA HPADSTMIDT SDNTVTVCMD YIKGRCMREK CKYFHPPAHL
241 QAKIKAAQHQ ANQAAVAAQA AAAAATVMAF PPGALHPLPK RQALEKSNGT SAVFNPSVLH
301 YQQALTSAQL QQHAAFIPTG SVLCMTPATS IDNSEIISRN GMECQESALR ITKHCYCTYY
361 PVSSSIELPQ TACLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MBNL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 90 nTPM
Expression across tissuesHPA
Tissue
- liver: 90 nTPM
- tongue: 83 nTPM
- spinal cord: 65 nTPM
- adrenal gland: 61 nTPM
- adipose tissue: 61 nTPM
- ovary: 54 nTPM
Single-cell type
- pancreatic acinar cells: 1,251 nCPM
- adrenal cortex cells: 912 nCPM
- oligodendrocytes: 793 nCPM
- rod photoreceptor cells: 664 nCPM
- extravillous trophoblasts: 651 nCPM
- thymic myoid cells: 612 nCPM
Immune cell
- basophil: 28 nTPM
- MAIT T-cell: 20 nTPM
- eosinophil: 18 nTPM
- memory B-cell: 18 nTPM
- gdT-cell: 17 nTPM
- naive B-cell: 17 nTPM
Brain region
- white matter: 211 nTPM
- basal ganglia: 144 nTPM
- cerebellum: 138 nTPM
- pons: 136 nTPM
- medulla oblongata: 130 nTPM
- midbrain: 126 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0.26
- gnomAD missense Z
- 2.79
- DepMap mean gene effect
- 0.2
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MBNL2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MBNL2 as an antibody target. Whether an autoantibody or antibody against MBNL2 could matter depends on whether native MBNL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MBNL2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MBNL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...